International Network of Chronic Kidney Disease cohort studies (iNET-CKD)

A global network of chronic kidney disease cohorts

Thomas Dienemann, Naohiko Fujii, Paula Orlandi, Lisa Nessel, Susan L. Furth, Wendy E. Hoy, Seiichi Matsuo, Gert Mayer, Shona Methven, Franz Schaefer, Elke S. Schaeffner, Laura Solá, Bénédicte Stengel, Christoph Wanner, Luxia Zhang, Adeera Levin, Kai Uwe Eckardt, Harold I. Feldman

Research output: Contribution to journalArticle

Abstract

Background: Chronic kidney disease (CKD) is a global health burden, yet it is still underrepresented within public health agendas in many countries. Studies focusing on the natural history of CKD are challenging to design and conduct, because of the long time-course of disease progression, a wide variation in etiologies, and a large amount of clinical variability among individuals with CKD. With the difference in health-related behaviors, healthcare delivery, genetics, and environmental exposures, this variability is greater across countries than within one locale and may not be captured effectively in a single study. Methods: Studies were invited to join the network. Prerequisites for membership included: 1) observational designs with a priori hypotheses and defined study objectives, patient-level information, prospective data acquisition and collection of bio-samples, all focused on predialysis CKD patients; 2) target sample sizes of 1,000 patients for adult cohorts and 300 for pediatric cohorts; and 3) minimum follow-up of three years. Participating studies were surveyed regarding design, data, and biosample resources. Results: Twelve prospective cohort studies and two registries covering 21 countries were included. Participants age ranges from >2 to >70 years at inclusion, CKD severity ranges from stage 2 to stage 5. Patient data and biosamples (not available in the registry studies) are measured yearly or biennially. Many studies included multiple ethnicities; cohort size ranges from 400 to more than 13,000 participants. Studies' areas of emphasis all include but are not limited to renal outcomes, such as progression to ESRD and death. Conclusions: iNET-CKD (International Network of CKD cohort studies) was established, to promote collaborative research, foster exchange of expertise, and create opportunities for research training. Participating studies have many commonalities that will facilitate comparative research; however, we also observed substantial differences. The diversity we observed across studies within this network will be able to be leveraged to identify genetic, behavioral, and health services factors associated with the course of CKD. With an emerging infrastructure to facilitate interactions among the investigators of iNET-CKD and a broadly defined research agenda, we are confident that there will be great opportunity for productive collaborative investigations involving cohorts of individuals with CKD.

Original languageEnglish (US)
Article number121
JournalBMC Nephrology
Volume17
Issue number1
DOIs
StatePublished - Sep 2 2016
Externally publishedYes

Fingerprint

Chronic Renal Insufficiency
Cohort Studies
Research
Registries
Genetic Services
Environmental Exposure
Sample Size
Chronic Kidney Failure
Health Services
Disease Progression
Public Health
Research Personnel
Prospective Studies
Pediatrics
Delivery of Health Care
Kidney
Health

Keywords

  • CKD
  • Cohort study
  • Diversity
  • Epidemiology
  • Network

ASJC Scopus subject areas

  • Nephrology

Cite this

Dienemann, T., Fujii, N., Orlandi, P., Nessel, L., Furth, S. L., Hoy, W. E., ... Feldman, H. I. (2016). International Network of Chronic Kidney Disease cohort studies (iNET-CKD): A global network of chronic kidney disease cohorts. BMC Nephrology, 17(1), [121]. https://doi.org/10.1186/s12882-016-0335-2

International Network of Chronic Kidney Disease cohort studies (iNET-CKD) : A global network of chronic kidney disease cohorts. / Dienemann, Thomas; Fujii, Naohiko; Orlandi, Paula; Nessel, Lisa; Furth, Susan L.; Hoy, Wendy E.; Matsuo, Seiichi; Mayer, Gert; Methven, Shona; Schaefer, Franz; Schaeffner, Elke S.; Solá, Laura; Stengel, Bénédicte; Wanner, Christoph; Zhang, Luxia; Levin, Adeera; Eckardt, Kai Uwe; Feldman, Harold I.

In: BMC Nephrology, Vol. 17, No. 1, 121, 02.09.2016.

Research output: Contribution to journalArticle

Dienemann, T, Fujii, N, Orlandi, P, Nessel, L, Furth, SL, Hoy, WE, Matsuo, S, Mayer, G, Methven, S, Schaefer, F, Schaeffner, ES, Solá, L, Stengel, B, Wanner, C, Zhang, L, Levin, A, Eckardt, KU & Feldman, HI 2016, 'International Network of Chronic Kidney Disease cohort studies (iNET-CKD): A global network of chronic kidney disease cohorts', BMC Nephrology, vol. 17, no. 1, 121. https://doi.org/10.1186/s12882-016-0335-2
Dienemann, Thomas ; Fujii, Naohiko ; Orlandi, Paula ; Nessel, Lisa ; Furth, Susan L. ; Hoy, Wendy E. ; Matsuo, Seiichi ; Mayer, Gert ; Methven, Shona ; Schaefer, Franz ; Schaeffner, Elke S. ; Solá, Laura ; Stengel, Bénédicte ; Wanner, Christoph ; Zhang, Luxia ; Levin, Adeera ; Eckardt, Kai Uwe ; Feldman, Harold I. / International Network of Chronic Kidney Disease cohort studies (iNET-CKD) : A global network of chronic kidney disease cohorts. In: BMC Nephrology. 2016 ; Vol. 17, No. 1.
@article{31b825ba20194f61b9b6b2fbbd928ea2,
title = "International Network of Chronic Kidney Disease cohort studies (iNET-CKD): A global network of chronic kidney disease cohorts",
abstract = "Background: Chronic kidney disease (CKD) is a global health burden, yet it is still underrepresented within public health agendas in many countries. Studies focusing on the natural history of CKD are challenging to design and conduct, because of the long time-course of disease progression, a wide variation in etiologies, and a large amount of clinical variability among individuals with CKD. With the difference in health-related behaviors, healthcare delivery, genetics, and environmental exposures, this variability is greater across countries than within one locale and may not be captured effectively in a single study. Methods: Studies were invited to join the network. Prerequisites for membership included: 1) observational designs with a priori hypotheses and defined study objectives, patient-level information, prospective data acquisition and collection of bio-samples, all focused on predialysis CKD patients; 2) target sample sizes of 1,000 patients for adult cohorts and 300 for pediatric cohorts; and 3) minimum follow-up of three years. Participating studies were surveyed regarding design, data, and biosample resources. Results: Twelve prospective cohort studies and two registries covering 21 countries were included. Participants age ranges from >2 to >70 years at inclusion, CKD severity ranges from stage 2 to stage 5. Patient data and biosamples (not available in the registry studies) are measured yearly or biennially. Many studies included multiple ethnicities; cohort size ranges from 400 to more than 13,000 participants. Studies' areas of emphasis all include but are not limited to renal outcomes, such as progression to ESRD and death. Conclusions: iNET-CKD (International Network of CKD cohort studies) was established, to promote collaborative research, foster exchange of expertise, and create opportunities for research training. Participating studies have many commonalities that will facilitate comparative research; however, we also observed substantial differences. The diversity we observed across studies within this network will be able to be leveraged to identify genetic, behavioral, and health services factors associated with the course of CKD. With an emerging infrastructure to facilitate interactions among the investigators of iNET-CKD and a broadly defined research agenda, we are confident that there will be great opportunity for productive collaborative investigations involving cohorts of individuals with CKD.",
keywords = "CKD, Cohort study, Diversity, Epidemiology, Network",
author = "Thomas Dienemann and Naohiko Fujii and Paula Orlandi and Lisa Nessel and Furth, {Susan L.} and Hoy, {Wendy E.} and Seiichi Matsuo and Gert Mayer and Shona Methven and Franz Schaefer and Schaeffner, {Elke S.} and Laura Sol{\'a} and B{\'e}n{\'e}dicte Stengel and Christoph Wanner and Luxia Zhang and Adeera Levin and Eckardt, {Kai Uwe} and Feldman, {Harold I.}",
year = "2016",
month = "9",
day = "2",
doi = "10.1186/s12882-016-0335-2",
language = "English (US)",
volume = "17",
journal = "BMC Nephrology",
issn = "1471-2369",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - International Network of Chronic Kidney Disease cohort studies (iNET-CKD)

T2 - A global network of chronic kidney disease cohorts

AU - Dienemann, Thomas

AU - Fujii, Naohiko

AU - Orlandi, Paula

AU - Nessel, Lisa

AU - Furth, Susan L.

AU - Hoy, Wendy E.

AU - Matsuo, Seiichi

AU - Mayer, Gert

AU - Methven, Shona

AU - Schaefer, Franz

AU - Schaeffner, Elke S.

AU - Solá, Laura

AU - Stengel, Bénédicte

AU - Wanner, Christoph

AU - Zhang, Luxia

AU - Levin, Adeera

AU - Eckardt, Kai Uwe

AU - Feldman, Harold I.

PY - 2016/9/2

Y1 - 2016/9/2

N2 - Background: Chronic kidney disease (CKD) is a global health burden, yet it is still underrepresented within public health agendas in many countries. Studies focusing on the natural history of CKD are challenging to design and conduct, because of the long time-course of disease progression, a wide variation in etiologies, and a large amount of clinical variability among individuals with CKD. With the difference in health-related behaviors, healthcare delivery, genetics, and environmental exposures, this variability is greater across countries than within one locale and may not be captured effectively in a single study. Methods: Studies were invited to join the network. Prerequisites for membership included: 1) observational designs with a priori hypotheses and defined study objectives, patient-level information, prospective data acquisition and collection of bio-samples, all focused on predialysis CKD patients; 2) target sample sizes of 1,000 patients for adult cohorts and 300 for pediatric cohorts; and 3) minimum follow-up of three years. Participating studies were surveyed regarding design, data, and biosample resources. Results: Twelve prospective cohort studies and two registries covering 21 countries were included. Participants age ranges from >2 to >70 years at inclusion, CKD severity ranges from stage 2 to stage 5. Patient data and biosamples (not available in the registry studies) are measured yearly or biennially. Many studies included multiple ethnicities; cohort size ranges from 400 to more than 13,000 participants. Studies' areas of emphasis all include but are not limited to renal outcomes, such as progression to ESRD and death. Conclusions: iNET-CKD (International Network of CKD cohort studies) was established, to promote collaborative research, foster exchange of expertise, and create opportunities for research training. Participating studies have many commonalities that will facilitate comparative research; however, we also observed substantial differences. The diversity we observed across studies within this network will be able to be leveraged to identify genetic, behavioral, and health services factors associated with the course of CKD. With an emerging infrastructure to facilitate interactions among the investigators of iNET-CKD and a broadly defined research agenda, we are confident that there will be great opportunity for productive collaborative investigations involving cohorts of individuals with CKD.

AB - Background: Chronic kidney disease (CKD) is a global health burden, yet it is still underrepresented within public health agendas in many countries. Studies focusing on the natural history of CKD are challenging to design and conduct, because of the long time-course of disease progression, a wide variation in etiologies, and a large amount of clinical variability among individuals with CKD. With the difference in health-related behaviors, healthcare delivery, genetics, and environmental exposures, this variability is greater across countries than within one locale and may not be captured effectively in a single study. Methods: Studies were invited to join the network. Prerequisites for membership included: 1) observational designs with a priori hypotheses and defined study objectives, patient-level information, prospective data acquisition and collection of bio-samples, all focused on predialysis CKD patients; 2) target sample sizes of 1,000 patients for adult cohorts and 300 for pediatric cohorts; and 3) minimum follow-up of three years. Participating studies were surveyed regarding design, data, and biosample resources. Results: Twelve prospective cohort studies and two registries covering 21 countries were included. Participants age ranges from >2 to >70 years at inclusion, CKD severity ranges from stage 2 to stage 5. Patient data and biosamples (not available in the registry studies) are measured yearly or biennially. Many studies included multiple ethnicities; cohort size ranges from 400 to more than 13,000 participants. Studies' areas of emphasis all include but are not limited to renal outcomes, such as progression to ESRD and death. Conclusions: iNET-CKD (International Network of CKD cohort studies) was established, to promote collaborative research, foster exchange of expertise, and create opportunities for research training. Participating studies have many commonalities that will facilitate comparative research; however, we also observed substantial differences. The diversity we observed across studies within this network will be able to be leveraged to identify genetic, behavioral, and health services factors associated with the course of CKD. With an emerging infrastructure to facilitate interactions among the investigators of iNET-CKD and a broadly defined research agenda, we are confident that there will be great opportunity for productive collaborative investigations involving cohorts of individuals with CKD.

KW - CKD

KW - Cohort study

KW - Diversity

KW - Epidemiology

KW - Network

UR - http://www.scopus.com/inward/record.url?scp=84985006699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985006699&partnerID=8YFLogxK

U2 - 10.1186/s12882-016-0335-2

DO - 10.1186/s12882-016-0335-2

M3 - Article

VL - 17

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

IS - 1

M1 - 121

ER -